Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2025-08-07 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about the progress of using idle funds for cash management, including specific investment products, amounts, dates, expected returns, risk control measures, and impact on the company. It is not a financial report like an annual or interim report, nor is it a regulatory certification or a brief announcement of a report. The content focuses on capital management activities and updates on financing-related investments. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive details about financing activities, not just a brief notice or regulatory filing.
2025-08-07 Chinese
关于投资设立葵花药业集团（哈尔滨）医药有限公司的进展公告
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding the progress of an investment to establish a wholly-owned subsidiary, including details about the new company's registration and business scope. It references a previous announcement about the investment and provides updated information on the registration completion and business license. The document is short (1320 characters) and serves as an update on a capital investment activity rather than a full financial report or detailed presentation. It does not contain financial statements or detailed analysis but is an official announcement about a financing-related event (establishing a subsidiary with capital investment). Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2025-08-05 Chinese
关于投资设立葵花大健康科技(吉安)有限公司的进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about the progress of an investment to establish a wholly-owned subsidiary. It includes details about the new company's registration, business scope, and legal representative. The document is short (1409 characters) and does not contain financial statements or detailed financial analysis. It is an update on a corporate action rather than a financial report or regulatory filing. This fits best under the category of a general regulatory announcement about corporate developments, which corresponds to Regulatory Filings (RNS).
2025-08-04 Chinese
关于收到葵花牌益生菌粉、小葵花牌益生菌粉注册申请受理通知书的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding the receipt of acceptance notices for registration applications of new probiotic powder products from the National Market Supervision Administration. It includes product details, regulatory references, and a risk warning about the approval process. The document is short (958 characters) and serves as a regulatory announcement about product registration status rather than a financial report, management change, or other specific filings. It does not contain financial data, voting results, or executive changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-07-31 Chinese
关于全资孙公司广东葵花医药有限公司减资进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a capital reduction (registered capital decrease) of a wholly-owned subsidiary of the company. It details the updated registered capital and related administrative updates such as the new business license. There is no financial report, earnings data, or detailed financial statements included. The document is a corporate announcement about a capital structure change at the subsidiary level, which fits the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the best classification is CAP.
2025-07-30 Chinese
关于投资设立全资子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company about its investment to establish two wholly-owned subsidiaries. It details the investment amount, company names, business scope, and strategic purpose. There are no financial statements, audit opinions, or detailed financial data. The document is relatively short (2184 characters) and serves as a formal public announcement of a corporate action related to capital investment and company structure. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as establishing subsidiaries with capital investment.
2025-07-25 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.